{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:49:51Z","timestamp":1770756591623,"version":"3.50.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.eprac.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:05:20Z","timestamp":1760544320000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and Associated Risk Factors for Venous Thromboembolism in a Large Cohort of Patients With Cushing Disease"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7187-1177","authenticated-orcid":false,"given":"Ana Julia","family":"Garcia Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Loch","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malebranche Berardo","family":"Carneiro Cunha-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter Angelo","family":"Sperling Cescato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Ochman da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Candida","family":"Barisson Villares Fragoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines Nobuko","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Glezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1673-3749","authenticated-orcid":false,"given":"Marcio Carlos","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eprac.2025.10.005_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.eprac.2025.10.005_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000315813","article-title":"Mortality in cushing\u2019s disease","volume":"92","author":"Clayton","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.005_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing\u2019s syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2025.10.005_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.005_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11102-023-01343-2","article-title":"Complications and mortality of Cushing\u2019s disease: report on data collected over a 20-year period at a referral centre","volume":"26","author":"Mondin","year":"2023","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.eprac.2025.10.005_bib6","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0046","article-title":"Venous thromboembolism in cushing syndrome: results from an EuRRECa and Endo-ERN survey","volume":"13","author":"Cherenko","year":"2024","journal-title":"Endocr Connect"},{"issue":"11","key":"10.1016\/j.eprac.2025.10.005_bib7","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with cushing\u2019s syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.10.005_bib8","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvz033","article-title":"Hypercoagulability in cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study","volume":"4","author":"Suarez","year":"2020","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.005_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ejendo\/lvad176","article-title":"High prevalence of venous thrombotic events in cushing\u2019s syndrome: data from ERCUSYN and details in relation to surgery","volume":"190","author":"Isand","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2025.10.005_bib10","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in cushing\u2019s syndrome: a systematic review","volume":"94","author":"Van Zaane","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.10.005_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12020-015-0665-z","article-title":"A venous thromboembolism risk assessment model for patients with cushing\u2019s syndrome","volume":"52","author":"Zilio","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.005_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11102-024-01482-0","article-title":"Can we predict the risk of venous thromboembolism in patients with Cushing\u2019s syndrome: a nationwide cohort analysis","volume":"28","author":"Rudman","year":"2025","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.005_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","article-title":"Cushing\u2019s syndrome","volume":"37","author":"Pivonello","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.005_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","article-title":"Hypercoagulability in cushing\u2019s syndrome: the role of specific haemostatic and fibrinolytic markers","volume":"36","author":"Kastelan","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2025.10.005_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous cushing\u2019s syndrome: a systematic meta-analysis","volume":"9","author":"Wagner","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.eprac.2025.10.005_bib16","first-page":"3662","article-title":"Anticoagulant prophylaxis markedly reduces thromboembolic complications in cushing\u2019s syndrome","volume":"87","author":"Boscaro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.005_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13023-022-02320-x","article-title":"Current clinical practice for thromboprophylaxis management in patients with Cushing\u2019s syndrome across reference centers of the european reference network on rare endocrine conditions (Endo-ERN)","volume":"17","author":"van Haalen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.005_bib18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s11102-022-01261-9","article-title":"Hypercoagulability in Cushing\u2019s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols","volume":"25","author":"Feelders","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.eprac.2025.10.005_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1350010","article-title":"The thrombotic risk in Cushing\u2019s Syndrome\u2014Questions, answers, and the algorithm to consider in its assessment: part I\u2014Thrombotic risk not related to surgery","volume":"15","author":"Bryk-Wi\u0105zania","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.005_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12959-023-00515-1","article-title":"Preventive strategies for hypercoagulation in cushing\u2019s syndrome: when and how","volume":"21","author":"Lopes","year":"2023","journal-title":"Thromb J"},{"issue":"12","key":"10.1016\/j.eprac.2025.10.005_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2025.10.005_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/2359-3997000000174","article-title":"Recommendations of the neuroendocrinology department of the Brazilian society of endocrinology and metabolism for the diagnosis of cushing\u2019s disease in Brazil","volume":"60","author":"Machado","year":"2016","journal-title":"Arch Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.10.005_bib23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1210\/jc.2009-1146","article-title":"Use of the desmopressin test in the differential diagnosis of pseudo-cushing state from cushing\u2019s disease","volume":"95","author":"Tirabassi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2025.10.005_bib24","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the padua prediction score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.eprac.2025.10.005_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41574-023-00868-7","article-title":"An individualized approach to the management of cushing disease","volume":"19","author":"Fleseriu","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.10.005_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11102-021-01195-8","article-title":"Venous thromboembolism chemical prophylaxis after endoscopic trans-sphenoidal pituitary surgery","volume":"25","author":"Waqar","year":"2022","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.eprac.2025.10.005_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3171\/jns.1999.91.2.0175","article-title":"Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing\u2019s disease","volume":"91","author":"Semple","year":"1999","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.eprac.2025.10.005_bib28","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/ejendo\/lvaf017","article-title":"Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous cushing\u2019s syndrome: a position statement","volume":"192","author":"Isand","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.005_bib29","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1038\/s41598-023-30070-8","article-title":"Prevalence of perioperative asymptomatic venous thromboses of the lower extremity in 30 consecutive patients undergoing transsphenoidal surgery for cushing\u2019s disease","volume":"13","author":"Huckhagel","year":"2023","journal-title":"Sci Rep"},{"issue":"Suppl 3","key":"10.1016\/j.eprac.2025.10.005_bib30","first-page":"304","article-title":"Clinical assessment of venous thromboembolic risk in surgical patients","volume":"17","author":"Caprini","year":"1991","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.005_bib31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11102-013-0522-0","article-title":"Elevated white blood cell counts in cushing\u2019s disease: association with hypercortisolism","volume":"17","author":"Masri-Iraqi","year":"2014","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.eprac.2025.10.005_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11102-024-01399-8","article-title":"Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing\u2019s syndrome: a large population database study","volume":"27","author":"Dery","year":"2024","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.005_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40618-023-02128-x","article-title":"Erythropoiesis in cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study","volume":"47","author":"Detomas","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"10.1016\/j.eprac.2025.10.005_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand\u2019s disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.005_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3171\/2022.1.PEDS21469","article-title":"Venous thromboembolism in the setting of pediatric central diabetes insipidus: a systematic review of the literature and report of 2 cases","volume":"29","author":"Lambert","year":"2022","journal-title":"J Neurosurg Pediatr"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25012534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25012534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:45:45Z","timestamp":1770738345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25012534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1530891X25012534"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.10.005","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Associated Risk Factors for Venous Thromboembolism in a Large Cohort of Patients With Cushing Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}